These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15930358)
1. Intraprostatic chemotherapy: distribution and transport mechanisms. Wientjes MG; Zheng JH; Hu L; Gan Y; Au JL Clin Cancer Res; 2005 Jun; 11(11):4204-11. PubMed ID: 15930358 [TBL] [Abstract][Full Text] [Related]
2. Computational modeling to predict effect of treatment schedule on drug delivery to prostate in humans. Hu L; Au JL; Wientjes MG Clin Cancer Res; 2007 Feb; 13(4):1278-87. PubMed ID: 17317840 [TBL] [Abstract][Full Text] [Related]
3. Biodegradable intraprostatic doxorubicin implants. Ortiz R; Au JL; Lu Z; Gan Y; Wientjes MG AAPS J; 2007 Jun; 9(2):E241-50. PubMed ID: 17907765 [TBL] [Abstract][Full Text] [Related]
4. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin. Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888 [TBL] [Abstract][Full Text] [Related]
5. Drug uptake in a rodent sarcoma model after intravenous injection or isolated lung perfusion of free/liposomal doxorubicin. Cheng C; Haouala A; Krueger T; Mithieux F; Perentes JY; Peters S; Decosterd LA; Ris HB Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):635-8. PubMed ID: 19282323 [TBL] [Abstract][Full Text] [Related]
6. Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposomal doxorubicin in the dog. Kiyokawa H; Igawa Y; Muraishi O; Katsuyama Y; Iizuka K; Nishizawa O J Urol; 1999 Feb; 161(2):665-7. PubMed ID: 9915479 [TBL] [Abstract][Full Text] [Related]
7. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers. Leakakos T; Ji C; Lawson G; Peterson C; Goodwin S Cancer Chemother Pharmacol; 2003 Jun; 51(6):445-50. PubMed ID: 12802508 [TBL] [Abstract][Full Text] [Related]
9. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors. Primeau AJ; Rendon A; Hedley D; Lilge L; Tannock IF Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8782-8. PubMed ID: 16361566 [TBL] [Abstract][Full Text] [Related]
10. An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancer. Kassouf W; Brown GA; Shetty A; Hazle JD; Stafford RJ; Rosser CJ; Stephens C; Tinkey PT; Pisters LL Urology; 2007 Oct; 70(4):822-5. PubMed ID: 17991580 [TBL] [Abstract][Full Text] [Related]
11. [Intralymphatic chemotherapy with adriamycin-adsorbing nanometric activated carbon:pharmacokinetic experiment with dogs]. Hua ZH; Cai SY; Huang GJ; Wu CT; Gan J; Hu CE; Ni QX; Zhang YL Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2299-301. PubMed ID: 19087684 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats. Wang JC; Liu XY; Lu WL; Chang A; Zhang Q; Goh BC; Lee HS Eur J Pharm Biopharm; 2006 Jan; 62(1):44-51. PubMed ID: 16126379 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113 [TBL] [Abstract][Full Text] [Related]
14. Effect of fibrous capsule formation on doxorubicin distribution in radiofrequency ablated rat livers. Blanco E; Qian F; Weinberg B; Stowe N; Anderson JM; Gao J J Biomed Mater Res A; 2004 Jun; 69(3):398-406. PubMed ID: 15127386 [TBL] [Abstract][Full Text] [Related]
15. Infusion rates and drug distribution in brain tumor models in rats. Khan A; Jallo GI; Liu YJ; Carson BS; Guarnieri M J Neurosurg; 2005 Jan; 102(1 Suppl):53-8. PubMed ID: 16206734 [TBL] [Abstract][Full Text] [Related]
16. Vascular targeting of doxorubicin using cationic liposomes. Wu J; Lee A; Lu Y; Lee RJ Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230 [TBL] [Abstract][Full Text] [Related]
17. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy? Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468 [TBL] [Abstract][Full Text] [Related]
18. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting]. Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941 [TBL] [Abstract][Full Text] [Related]
19. [Targeting delivery of liposomal adriamycin by intra-lymphatic infusion]. Feng B; Lang J; Li D Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):156-8. PubMed ID: 9596890 [TBL] [Abstract][Full Text] [Related]
20. Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy. Ranney D; Antich P; Dadey E; Mason R; Kulkarni P; Singh O; Chen H; Constantanescu A; Parkey R J Control Release; 2005 Dec; 109(1-3):222-35. PubMed ID: 16290245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]